Preston Klassen
2010 - Orexigen Therapeutics
In 2010, Preston Klassen earned a total compensation of $1M as Head of Global Contrave Program and Senior Vice President, Product Development at Orexigen Therapeutics, a 14% decrease compared to previous year.
Compensation breakdown
Bonus | $395,000 |
---|---|
Option Awards | $285,311 |
Salary | $332,052 |
Other | $120 |
Total | $1,012,483 |
Klassen received $395K in bonus, accounting for 39% of the total pay in 2010.
Klassen also received $285.3K in option awards, $332.1K in salary and $120 in other compensation.
Rankings
In 2010, Preston Klassen's compensation ranked 5,265th out of 10,439 executives tracked by ExecPay. In other words, Klassen earned more than 49.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,265 | 50th |
Manufacturing | 1,899 | 51st |
Chemicals And Allied Products | 393 | 57th |
Drugs | 232 | 66th |
Pharmaceutical Preparations | 177 | 63rd |
Klassen's colleagues
We found five more compensation records of executives who worked with Preston Klassen at Orexigen Therapeutics in 2010.
2010
Michael Narachi
Orexigen Therapeutics
Chief Executive Officer
2010
Heather Turner
Orexigen Therapeutics
General Counsel
2010
Mark Booth
Orexigen Therapeutics
Chief Commercial Officer
2010
Graham Cooper
Orexigen Therapeutics
Chief Financial Officer
2010
Joseph Hagan
Orexigen Therapeutics